Trevena Announces Presentations of OLINVYK® Health Economic Models at ISPOR 2021
19 mai 2021 07h00 HE
|
Trevena Inc.
-- Models demonstrate substantial overall cost savings for hospitals when using OLINVYK compared to IV morphine in postoperative care -- CHESTERBROOK, Pa., May 19, 2021 (GLOBE NEWSWIRE) --...
Kiniksa to Present Data on the Burden of Disease in Patients with Recurrent Pericarditis at the International Society for Pharmacoeconomics and Outcomes Research
16 mai 2019 07h30 HE
|
Kiniksa Pharmaceuticals, Ltd.
HAMILTON, Bermuda, May 16, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and...
ISPOR Addresses New Challenges for Improving European Health Care at Annual European Congress
07 oct. 2014 08h00 HE
|
ISPOR
PRINCETON, N.J., Oct. 7, 2014 (GLOBE NEWSWIRE) -- The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) will hold its 17th Annual European Congress in Amsterdam from November...
Photo Release -- The International Society for Pharmacoeconomics and Outcomes Research Announces New CEO and Executive Director
17 sept. 2014 08h30 HE
|
ISPOR
PRINCETON, N.J., Sept. 17, 2014 (GLOBE NEWSWIRE) -- The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is pleased to announce that Nancy S. Berg will join the Society on...
ISPOR Asia-Pacific Conference in Beijing, China to Focus on Health Care Reform, Big Data, and Patients in Asia
18 août 2014 21h30 HE
|
ISPOR
PRINCETON, N.J., Aug. 18, 2014 (GLOBE NEWSWIRE) -- The International Society for Pharmacoeconomics and Outcomes Research (ISPOR), in conjunction with the ISPOR Asia Consortium, and the China...
Collaboration Between Regulators and HTA Organizations to Improve Health Care Decision Making
25 juin 2014 10h49 HE
|
ISPOR
PRINCETON, N.J., June 25, 2014 (GLOBE NEWSWIRE) -- As announced today by the European network for Health Technology Assessment (EUnetHTA) and European Medicines Agency (EMA), Value in Health, the...